This nuclear receptor not only transcriptionally activates DAT expression (Sacchetti et al, 2001), but is also involved in several brain disorders, such as Parkinson’s disease (Willems and Merk, 2022). This evidence concerns the gene SLC6A3 and Parkinson disease.